| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $168,201,431 ) (Continued on the next page) |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM144117 | Construction of in vivo mRNA delivery systems | 001 | 6 | NIH | 3/16/2026 | $46,475 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM144117 | Construction of in vivo mRNA delivery systems | 000 | 6 | NIH | 1/16/2026 | $418,275 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R18HS029126 | Improving Outcomes in Chronic Intestinal Failure Using the ECHO Model: The LIFT-ECHO Last Mile Project | 000 | 4 | AHRQ | 4/21/2026 | $393,437 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI187731 | CRISPR-Cas9 base editing approaches to discover ubiquitination events promoting flavivirus infection | 000 | 2 | NIH | 12/1/2025 | $211,250 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI191344 | Peptide-conjugated phosphodiamidate morpholino oligonucleotide (PPMO)-based henipavirus therapeutics | 000 | 1 | NIH | 3/30/2026 | $475,339 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03AI196368 | Pilot project to elucidate the role of DDX60L in Ebola virus disease | 000 | 1 | NIH | 4/28/2026 | $183,875 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R13HG014713 | Training the Internal Medicine Workforce for Implementing Genomic Medicine | 000 | 1 | NIH | 3/11/2026 | $74,909 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03TR005349 | Leveraging a lung organoid model to study early cystic fibrosis lung disease | 000 | 1 | NIH | 5/5/2026 | $168,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R13AG087672 | Exposomics and Alzheimer's disease Across the Life Course | 000 | 3 | NIH | 4/17/2026 | $50,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135728 | Investigating the Neurobiology of Early Cognitive Impairment | 000 | 3 | NIH | 1/14/2026 | $163,927 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136590 | Closed-loop Control of Interneuron Spike Timing in Epilepsy | 000 | 3 | NIH | 2/19/2026 | $525,573 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS138507 | Structural Pharmacology of GIRK Channel Disease Mutants | 000 | 2 | NIH | 3/24/2026 | $520,062 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135228 | Mediterranean Diet, Biological Aging, and Risk for Disease and Disability Progression in Multiple Sclerosis | 001 | 3 | NIH | 4/10/2026 | $16,955 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136523 | Computational Model of Neurocognitive Impairment in Multiple Sclerosis | 000 | 2 | NIH | 3/4/2026 | $584,334 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135228 | Mediterranean Diet, Biological Aging, and Risk for Disease and Disability Progression in Multiple Sclerosis | 000 | 3 | NIH | 3/31/2026 | $424,502 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136202 | Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | 002 | 2 | NIH | 4/23/2026 | $63,693 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136202 | Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | 001 | 2 | NIH | 1/13/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135728 | Investigating the Neurobiology of Early Cognitive Impairment | 001 | 3 | NIH | 2/25/2026 | $79,629 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136202 | Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | 000 | 2 | NIH | 12/19/2025 | $573,253 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01AI160082 | Childhood Asthma in Urban Settings | 000 | 6 | NIH | 4/17/2026 | $433,302 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | T32MH135853 | Training Program in Social Neuroscience Research | 000 | 3 | NIH | 4/3/2026 | $274,727 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | T32HL160511 | Multidisciplinary Research Training in Sleep Science | 000 | 4 | NIH | 1/31/2026 | $392,778 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R50CA276021 | NCI Research Specialist (Clinician Scientist) Award | 000 | 4 | NIH | 3/19/2026 | $91,123 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | RF1NS115268 | The Late Effects of TBI (LETBI) Study: Injury Patterns and Biological Markers of Post-Traumatic Neurodegeneration | 001 | 2 | NIH | 3/12/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | RF1NS115268 | The Late Effects of TBI (LETBI) Study: Injury Patterns and Biological Markers of Post-Traumatic Neurodegeneration | 000 | 2 | NIH | 2/10/2026 | $3,354,854 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | RF1MH131537 | Global mapping of altered neural circuits in a mouse model of DDX3X mutations | 000 | 4 | NIH | 5/5/2026 | $1,664,276 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | RF1NS106721 | Transcriptional control of microglia diversification and inflammation | 000 | 6 | NIH | 5/4/2026 | $2,010,085 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R61CA297881 | High-throughput single-cell joint RNA and DNA methylation mapping of Acute Myeloid Leukemia | 000 | 2 | NIH | 3/4/2026 | $237,023 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35ES030435 | Early Warning Systems for Childhood and Adult Disorders | 000 | 7 | NIH | 3/31/2026 | $902,920 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM137905 | Mapping the Dynamic Interactome of Ig-fold Membrane Proteins Using Nanobody-Based Tools | 001 | 6 | NIH | 2/13/2026 | $462,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM139655 | High Resolution Characterization of Bacterial Epigenomes and Microbiome | 000 | 6 | NIH | 5/5/2026 | $798,207 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM124836 | Computational approaches to advance genomic, biological and clinical understandings of human disease | 000 | 9 | NIH | 2/23/2026 | $453,075 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM127103 | Wnt/Frizzled-PCP signaling in development and disease | 000 | 9 | NIH | 4/6/2026 | $666,310 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM127289 | Cyclin-dependent kinase control of cell-division and transcription cycles | 001 | 9 | NIH | 3/18/2026 | $50,700 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM127289 | Cyclin-dependent kinase control of cell-division and transcription cycles | 000 | 9 | NIH | 1/30/2026 | $456,300 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R25CA236636 | Training Cancer Care Providers to Implement Sensitive Practice Guidelines When Treating Adult Survivors of Sexual Violence: A Blended Learning Approach | 000 | 6 | NIH | 5/1/2026 | $196,303 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R33DA056779 | Cue Reactivity Modulation in Methamphetamine Use Disorder | 000 | 3 | NIH | 3/19/2026 | $834,725 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R25HL108857 | Short-term Research Education Program in Multidisciplinary Health-Related Research | 000 | 13 | NIH | 4/29/2026 | $164,589 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21HD113986 | Resolving the relationship between mitochondrial dysfunction and the impact of non-syndromic autism spectrum disorder-related risk genes on neuronal structure and function | 000 | 2 | NIH | 5/1/2026 | $211,250 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21EY037046 | Reconstruction of a human blood-retina barrier and perfused vascular system to investigate the role of APOE variants in age-related macular degeneration | 000 | 2 | NIH | 2/3/2026 | $211,250 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R24ES028522 | The Programming Research in Obesity, GRowth, Environment and Social Stress (PROGRESS) Cohort | 002 | 8 | NIH | 4/24/2026 | $40,189 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U19AG060917 | FSH - an Aging Hormone? | 000 | 8 | NIH | 4/28/2026 | $4,144,111 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24AG087563 | The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level | 000 | 3 | NIH | 4/17/2026 | $1,471,871 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24AG087563 | The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level | 000 | 3 | NIH | 4/17/2026 | $1,000,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U2CTR004867 | Translational center for kidney microphysiological systems to improve drug safety and efficacy | 000 | 4 | NIH | 2/11/2026 | $1,614,842 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24NS135391 | New York City Collaborative Regional Coordinating Center (NYCC-RCC) | 000 | 3 | NIH | 2/19/2026 | $432,711 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U19AI135972 | SARS-CoV adaptations through a Systems Biology Lens (SYBIL) | 000 | 9 | NIH | 1/13/2026 | $2,510,205 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U19AI168631 | Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC) | 000 | 5 | NIH | 3/23/2026 | $2,265,730 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01EB035521 | Development of novel lipid nanoparticles for nucleic acids delivery in the brain | 000 | 2 | NIH | 3/27/2026 | $843,806 |
|
